A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma

<div>Response to immunotherapy in high- and low-risk groups. (a) Scores for immune responses in two groups. (b) Proportion of immune responses in two groups.</div>

Analytical Cellular Pathology

fig9

Figure 9

Figure 9: A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma 